Advisors Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $556K | Sell |
8,861
-230
| -3% | -$16K | 0.01% | 936 |
|
|
2025
Q4 | $603K | Sell |
9,091
-2,721
| -23% | -$176K | 0.01% | 906 |
|
|
2025
Q3 | $795K | Buy |
11,812
+397
| +3% | +$31.4K | 0.01% | 860 |
|
|
2025
Q2 | $996K | Sell |
11,415
-1,259
| -10% | -$98.7K | 0.02% | 775 |
|
|
2025
Q1 | $866K | Buy |
12,674
+726
| +6% | +$59.2K | 0.02% | 791 |
|
|
2024
Q4 | $929K | Buy |
11,948
+3,157
| +36% | +$234K | 0.02% | 761 |
|
|
2024
Q3 | $589K | Sell |
8,791
-6,096
| -41% | -$501K | 0.01% | 886 |
|
|
2024
Q2 | $1.69M | Buy |
14,887
+87
| +0.6% | +$11K | 0.03% | 578 |
|
|
2024
Q1 | $2.05M | Buy |
14,800
+1,809
| +14% | +$227K | 0.04% | 546 |
|
|
2023
Q4 | $1.61M | Sell |
12,991
-3,300
| -20% | -$337K | 0.03% | 593 |
|
|
2023
Q3 | $1.52M | Buy |
16,291
+1,588
| +11% | +$179K | 0.03% | 584 |
|
|
2023
Q2 | $1.89M | Buy |
14,703
+6,914
| +89% | +$836K | 0.04% | 526 |
|
|
2023
Q1 | $905K | Sell |
7,789
-130
| -2% | -$14.6K | 0.02% | 788 |
|
|
2022
Q4 | $897K | Sell |
7,919
-9,709
| -55% | -$1.07M | 0.02% | 780 |
|
|
2022
Q3 | $1.42M | Sell |
17,628
-1,094
| -6% | -$92.7K | 0.03% | 596 |
|
|
2022
Q2 | $1.4M | Sell |
18,722
-11,026
| -37% | -$1.01M | 0.03% | 639 |
|
|
2022
Q1 | $3.81M | Sell |
29,748
-4,396
| -13% | -$481K | 0.06% | 354 |
|
|
2021
Q4 | $4.58M | Buy |
34,144
+4,812
| +16% | +$691K | 0.07% | 323 |
|
|
2021
Q3 | $4.01M | Sell |
29,332
-4,136
| -12% | -$522K | 0.06% | 340 |
|
|
2021
Q2 | $3.57M | Sell |
33,468
-4,280
| -11% | -$411K | 0.05% | 371 |
|
|
2021
Q1 | $3.39M | Sell |
37,748
-240
| -0.6% | -$22.5K | 0.05% | 387 |
|
|
2020
Q4 | $3.51M | Sell |
37,988
-56
| -0.1% | -$5K | 0.06% | 337 |
|
|
2020
Q3 | $3.92M | Buy |
38,044
+4,176
| +12% | +$436K | 0.07% | 259 |
|
|
2020
Q2 | $3.43M | Buy |
33,868
+1,168
| +4% | +$104K | 0.07% | 291 |
|
|
2020
Q1 | $2.2M | Buy |
32,700
+3,056
| +10% | +$190K | 0.05% | 360 |
|
|
2019
Q4 | $1.62M | Sell |
29,644
-100
| -0.3% | -$4.74K | 0.03% | 605 |
|
|
2019
Q3 | $1.11M | Buy |
29,744
+4,476
| +18% | +$174K | 0.02% | 714 |
|
|
2019
Q2 | $947K | Buy |
25,268
+636
| +3% | +$20K | 0.02% | 801 |
|
|
2019
Q1 | $733K | Buy |
24,632
+1,604
| +7% | +$56.4K | 0.01% | 944 |
|
|
2018
Q4 | $690K | Buy |
23,028
+20,324
| +752% | +$645K | 0.01% | 888 |
|
|
2018
Q3 | $97K | Buy |
2,704
+676
| +33% | +$21K | ﹤0.01% | 1364 |
|
|
2018
Q2 | $48K | Sell |
2,028
-4,772
| -70% | -$101K | ﹤0.01% | 1434 |
|
|
2018
Q1 | $95K | Sell |
6,800
-2,884
| -30% | -$42.6K | ﹤0.01% | 1318 |
|
|
2017
Q4 | $139K | Sell |
9,684
-1,004
| -9% | -$13.1K | ﹤0.01% | 1303 |
|
|
2017
Q3 | $131K | Sell |
10,688
-4,364
| -29% | -$77.1K | ﹤0.01% | 1308 |
|
|
2017
Q2 | $275K | Sell |
15,052
-17,664
| -54% | -$326K | ﹤0.01% | 1225 |
|
|
2017
Q1 | $693K | Buy |
32,716
+1,288
| +4% | +$25.1K | 0.01% | 986 |
|
|
2016
Q4 | $469K | Sell |
31,428
-3,592
| -10% | -$63.6K | 0.01% | 1139 |
|
|
2016
Q3 | $767K | Buy |
35,020
+22,704
| +184% | +$505K | 0.01% | 954 |
|
|
2016
Q2 | $244K | Sell |
12,316
-24,072
| -66% | -$410K | ﹤0.01% | 1302 |
|
|
2016
Q1 | $618K | Buy |
36,388
+384
| +1% | +$6.42K | 0.01% | 1010 |
|
|
2015
Q4 | $737K | Buy |
36,004
+9,024
| +33% | +$188K | 0.01% | 1007 |
|
|
2015
Q3 | $579K | Buy |
+26,980
| New | +$602K | 0.01% | 1034 |
|
Other funds holding DXCM
VCM
VPM
Advisors Asset Management's DXCM Position: Q1 2026 in Review
Advisors Asset Management reduced its DexCom (DXCM) stake by 2.5% in Q1 2026, selling an estimated $16K and leaving 8,861 shares worth $556K. The position accounts for 0.01% of the portfolio, ranked #936.
Advisors Asset Management first reported a position in DXCM in Q3 2015 and has held it in 43 quarters since. The position peaked at $4.58M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Advisors Asset Management held 8,861 shares of DexCom worth $556K as of Q1 2026.
- Advisors Asset Management sold 230 DexCom shares in Q1 2026, an estimated $16K.
- DexCom made up 0.01% of Advisors Asset Management's portfolio in Q1 2026, its #936 holding.
- Advisors Asset Management first reported a position in DexCom in Q3 2015 and has held it in 43 quarters since.
- Advisors Asset Management's DexCom position peaked at $4.58M in Q4 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.